ravulizumab-cwvz 300 MG in 30 ML Injection

RxCUI: 2107320
RxNorm name: ravulizumab-cwvz 300 MG in 30 ML Injection
Display name: ravulizumab-cwvz 300 MG in 30 ML Injection
Full name: ravulizumab-cwvz 300 MG in 30 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:14

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761108	Ultomiris	ravulizumab-cwvz	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ultomiris	RAVULIZUMAB	Alexion Pharmaceuticals Inc.	a9a590d9-0217-43c7-908d-e62a71279791	2025-10-09	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2107320

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
a9a590d9-0217-43c7-908d-e62a71279791	ravulizumab-cwvz 300 MG in 30 ML Injection	PSN	19	These highlights do not include all the information needed to use ULTOMIRIS safely and effectively. See full prescribing information for ULTOMIRIS. ULTOMIRIS ® (ravulizumab-cwvz) injection, for intravenous use Initial U.S. Approval: 2018	20251009
a9a590d9-0217-43c7-908d-e62a71279791	ravulizumab-cwvz 300 MG per 30 ML Injection	SY	19	These highlights do not include all the information needed to use ULTOMIRIS safely and effectively. See full prescribing information for ULTOMIRIS. ULTOMIRIS ® (ravulizumab-cwvz) injection, for intravenous use Initial U.S. Approval: 2018	20251009
a9a590d9-0217-43c7-908d-e62a71279791	30 ML ravulizumab-cwvz 10 MG/ML Injection	SCD	19	These highlights do not include all the information needed to use ULTOMIRIS safely and effectively. See full prescribing information for ULTOMIRIS. ULTOMIRIS ® (ravulizumab-cwvz) injection, for intravenous use Initial U.S. Approval: 2018	20251009